Medicare Enrolled

Dr. Amanda Kimmel, APRN

Gerontology Nurse Practitioner · Tampa, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
3000 MEDICAL PARK DR STE 250, Tampa, FL 33613
8136326220
In practice since 2021 (5 years)
NPI: 1609461581 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kimmel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kimmel? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kimmel

Dr. Amanda Kimmel is a gerontology nurse practitioner in Tampa, FL, with 5 years in practice. Based on federal Medicare data, Dr. Kimmel performed 48 Medicare services across 41 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kimmel received a total of $7,180 from 52 pharmaceutical and/or device companies across 304 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gerontology nurse practitioner. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kimmel is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 5 years in practice▲ 48 Medicare services$ $7,180 industry payments

Medicare Practice Summary

Medicare Utilization ↗
48
Medicare services
Bottom 14% in FL for gerontology nurse practitioner
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
41
Unique beneficiaries
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~10 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Complete blood count (CBC) with differential25$8$29
Blood draw (venipuncture)23$8$9
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$7,180
Total received (2021-2024)
Avg $1,795/year across 4 years
Top 4% in FL for gerontology nurse practitioner
52
Companies
304
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,808 (80.9%)
Other
Charitable contributions, space rental, and other categories
$1,371 (19.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,703
2023
$1,601
2022
$1,381
2021
$494

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$1,716
AstraZeneca Pharmaceuticals LP
$432
E.R. Squibb & Sons, L.L.C.
$364
PFIZER INC.
$350
Merck Sharp & Dohme LLC
$337
Eisai Inc.
$293
Janssen Biotech, Inc.
$253
Gilead Sciences, Inc.
$232
Celgene Corporation
$220
Bayer Healthcare Pharmaceuticals Inc.
$210
Takeda Pharmaceuticals U.S.A., Inc.
$199
Seagen Inc.
$177
Incyte Corporation
$177
Astellas Pharma US Inc
$173
Lilly USA, LLC
$145
BeiGene USA, Inc.
$124
Rigel Pharmaceuticals, Inc.
$98
Amgen Inc.
$96
Bayer HealthCare Pharmaceuticals Inc.
$89
Stemline Therapeutics Inc.
$84
Sirtex Medical Inc
$81
ARRAY BIOPHARMA INC
$73
AVEO Pharmaceuticals, Inc.
$71
ABBVIE INC.
$71
GENZYME CORPORATION
$70
SOBI, INC
$67
Boehringer Ingelheim Pharmaceuticals, Inc.
$63
Genentech USA, Inc.
$60
CTI BioPharma Corp.
$60
GlaxoSmithKline, LLC.
$56
Deciphera Pharmaceuticals Inc.
$56
TerSera Therapeutics LLC
$53
Myovant Sciences Inc.
$50
Merck Sharp & Dohme Corporation
$47
Genmab U.S., Inc.
$44
Exelixis Inc.
$40
Regeneron Healthcare Solutions, Inc.
$40
JAZZ PHARMACEUTICALS INC.
$39
Pharmacosmos Therapeutics Inc.
$39
Puma Biotechnology, Inc.
$39
EISAI INC.
$37
Karyopharm Therapeutics Inc.
$33
Ipsen Biopharmaceuticals, Inc
$33
Telix Pharmaceuticals
$25
Alexion Pharmaceuticals, Inc.
$25
Kite Pharma, Inc.
$23
Dendreon Pharmaceuticals LLC
$23
Aveo Pharmaceuticals, Inc.
$21
AMAG Pharmaceuticals, Inc.
$21
Sumitomo Pharma America, Inc.
$19
Acceleron Pharma, Inc.
$18
EMD Serono, Inc.
$14
Top 3 companies account for 35.0% of total payments
Associated products mentioned in payments ›
ADCETRIS · ALUNBRIG · Alecensa · BAVENCIO · BOSULIF · BRAFTOVI · BRUKINSA · CABOMETYX · CALQUENCE · CYRAMZA · DARZALEX · ELIQUIS · ELREXFIO · ENHERTU · EPKINLY · Epkinly · FERAHEME · FOTIVDA · FRUZAQLA · Fabhalta · GAZYVA · GILOTRIF · IBRANCE · ILLUCCIX · IMBRUVICA · IMFINZI · INLYTA · JAKAFI · KEYTRUDA · KISQALI · LIBTAYO · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MONOFERRIC · NERLYNX · Nplate · Nubeqa · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · PROVENGE · Padcev · Pomalyst · QINLOCK · REBLOZYL · Reblozyl · Rezlidhia · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SYNAGIS · Stivarga · TAGRISSO · TECVAYLI · TEVIMBRA · TIVDAK · TUKYSA · Tecentriq · Trodelvy · VERZENIO · VONJO · Vitrakvi · Vonjo · XALKORI · XPOVIO · Xermelo · Xospata · Yescarta · ZEPZELCA · Zoladex
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (81%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 4% for gerontology nurse practitioner in FL.

Equivalent to $14,958 per 100 Medicare services performed
Looking for a gerontology nurse practitioner in Tampa?
Compare gerontology nurse practitioners in the Tampa area by procedure volume, costs, and industry payment transparency.
Browse gerontology nurse practitioners nearby

Geographic Context

Gerontology Nurse Practitioners within 10 mi
161
Per 100K population
10.8
County median income
$75,011
Nearest hospital
ADVENTHEALTH TAMPA
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Kimmel is a mixed practice specialist, with moderate Medicare volume, and high industry engagement (low-engagement, top 4%).

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Kimmel experienced with complete blood count (cbc) with differential?
Based on Medicare claims data, Dr. Kimmel performed 25 complete blood count (cbc) with differential services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kimmel receive payments from pharmaceutical companies?
Yes. Dr. Kimmel received a total of $7,180 from 52 companies across 304 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kimmel's costs compare to other gerontology nurse practitioners in Tampa?
Dr. Kimmel's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kimmel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →